These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 16223872

  • 1. 5-Hydroxytryptamine 1A receptor blockade facilitates aversive learning in mice: interactions with cholinergic and glutamatergic mechanisms.
    Madjid N, Tottie EE, Lüttgen M, Meister B, Sandin J, Kuzmin A, Stiedl O, Ogren SO.
    J Pharmacol Exp Ther; 2006 Feb; 316(2):581-91. PubMed ID: 16223872
    [Abstract] [Full Text] [Related]

  • 2. Analysis of the role of 5-HT1A receptors in spatial and aversive learning in the rat.
    Lüttgen M, Elvander E, Madjid N, Ogren SO.
    Neuropharmacology; 2005 May; 48(6):830-52. PubMed ID: 15829255
    [Abstract] [Full Text] [Related]

  • 3. Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties.
    Schechter LE, Smith DL, Rosenzweig-Lipson S, Sukoff SJ, Dawson LA, Marquis K, Jones D, Piesla M, Andree T, Nawoschik S, Harder JA, Womack MD, Buccafusco J, Terry AV, Hoebel B, Rada P, Kelly M, Abou-Gharbia M, Barrett JE, Childers W.
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1274-89. PubMed ID: 15951399
    [Abstract] [Full Text] [Related]

  • 4. 5-HT(1A) and NMDA receptors interact in the rat medial septum and modulate hippocampal-dependent spatial learning.
    Elvander-Tottie E, Eriksson TM, Sandin J, Ogren SO.
    Hippocampus; 2009 Dec; 19(12):1187-98. PubMed ID: 19309036
    [Abstract] [Full Text] [Related]

  • 5. Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission.
    Eriksson TM, Madjid N, Elvander-Tottie E, Stiedl O, Svenningsson P, Ogren SO.
    Neuropharmacology; 2008 Jun; 54(7):1041-50. PubMed ID: 18394658
    [Abstract] [Full Text] [Related]

  • 6. Bidirectional modulation of classical fear conditioning in mice by 5-HT(1A) receptor ligands with contrasting intrinsic activities.
    Youn J, Misane I, Eriksson TM, Millan MJ, Ogren SO, Verhage M, Stiedl O.
    Neuropharmacology; 2009 Jun; 57(5-6):567-76. PubMed ID: 19607850
    [Abstract] [Full Text] [Related]

  • 7. Electrophysiological comparison of 5-Hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing.
    Martin LP, Jackson DM, Wallsten C, Waszczak BL.
    J Pharmacol Exp Ther; 1999 Feb; 288(2):820-6. PubMed ID: 9918594
    [Abstract] [Full Text] [Related]

  • 8. The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysis.
    Millan MJ, Gobert A, Roux S, Porsolt R, Meneses A, Carli M, Di Cara B, Jaffard R, Rivet JM, Lestage P, Mocaer E, Peglion JL, Dekeyne A.
    J Pharmacol Exp Ther; 2004 Oct; 311(1):190-203. PubMed ID: 15146031
    [Abstract] [Full Text] [Related]

  • 9. The selective 5-hydroxytryptamine 1A antagonist, AZD7371 [3(R)-(N,N-dicyclobutylamino)-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide (R,R)-tartrate monohydrate] (robalzotan tartrate monohydrate), inhibits visceral pain-related visceromotor, but not autonomic cardiovascular, responses to colorectal distension in rats.
    Lindström E, Ravnefjord A, Brusberg M, Hjorth S, Larsson H, Martinez V.
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1048-55. PubMed ID: 19325032
    [Abstract] [Full Text] [Related]

  • 10. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.
    Misane I, Johansson C, Ogren SO.
    Br J Pharmacol; 1998 Oct; 125(3):499-509. PubMed ID: 9806333
    [Abstract] [Full Text] [Related]

  • 11. The effects of selective antagonists of serotonin 5-HT7 and 5-HT1A receptors on MK-801-induced impairment of learning and memory in the passive avoidance and Morris water maze tests in rats: mechanistic implications for the beneficial effects of the novel atypical antipsychotic lurasidone.
    Horisawa T, Ishibashi T, Nishikawa H, Enomoto T, Toma S, Ishiyama T, Taiji M.
    Behav Brain Res; 2011 Jun 20; 220(1):83-90. PubMed ID: 21277905
    [Abstract] [Full Text] [Related]

  • 12. Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1a receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405).
    Hirst WD, Andree TH, Aschmies S, Childers WE, Comery TA, Dawson LA, Day M, Feingold IB, Grauer SM, Harrison BL, Hughes ZA, Kao J, Kelly MG, van der Lee H, Rosenzweig-Lipson S, Saab AL, Smith DL, Sullivan K, Rizzo SJ, Tio C, Zhang MY, Schechter LE.
    J Pharmacol Exp Ther; 2008 Apr 20; 325(1):134-45. PubMed ID: 18182558
    [Abstract] [Full Text] [Related]

  • 13. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats.
    Liu FY, Xing GG, Qu XX, Xu IS, Han JS, Wan Y.
    J Pharmacol Exp Ther; 2007 Jun 20; 321(3):1046-53. PubMed ID: 17329553
    [Abstract] [Full Text] [Related]

  • 14. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat.
    Wang S, Zhang QJ, Liu J, Wu ZH, Wang T, Gui ZH, Chen L, Wang Y.
    Neuroscience; 2009 Mar 17; 159(2):850-61. PubMed ID: 19174182
    [Abstract] [Full Text] [Related]

  • 15. Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181.
    Hillegaart V, Ahlenius S.
    Br J Pharmacol; 1998 Dec 17; 125(8):1733-43. PubMed ID: 9886765
    [Abstract] [Full Text] [Related]

  • 16. The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299.
    Johansson L, Sohn D, Thorberg SO, Jackson DM, Kelder D, Larsson LG, Rényi L, Ross SB, Wallsten C, Eriksson H, Hu PS, Jerning E, Mohell N, Westlind-Danielsson A.
    J Pharmacol Exp Ther; 1997 Oct 17; 283(1):216-25. PubMed ID: 9336327
    [Abstract] [Full Text] [Related]

  • 17. WAY 405, a new silent 5-HT (1A) receptor antagonist with low affinity for vascular alpha (1)-adrenoceptors.
    Villalobos-Molina R, Orozco-Méndez M, López-Guerrero JJ, Gallardo-Ortíz IA.
    Auton Autacoid Pharmacol; 2005 Oct 17; 25(4):185-9. PubMed ID: 16176451
    [Abstract] [Full Text] [Related]

  • 18. 5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT(1A) receptor stimulation on contextual learning in mice.
    Eriksson TM, Golkar A, Ekström JC, Svenningsson P, Ogren SO.
    Eur J Pharmacol; 2008 Oct 31; 596(1-3):107-10. PubMed ID: 18789922
    [Abstract] [Full Text] [Related]

  • 19. Stimulation of 5-HT(1A) receptors in the dorsal raphe ameliorates the impairment of spatial learning caused by intrahippocampal 7-chloro-kynurenic acid in naive and pretrained rats.
    Carli M, Balducci C, Samanin R.
    Psychopharmacology (Berl); 2001 Oct 31; 158(1):39-47. PubMed ID: 11685382
    [Abstract] [Full Text] [Related]

  • 20. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA, Lestienne F, Grevoz-Barret C, Newman-Tancredi A, Cussac D.
    Eur J Pharmacol; 2009 Oct 12; 620(1-3):27-35. PubMed ID: 19695244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.